Key points are not available for this paper at this time.
Abstract The Diabetes and Ramadan (DAR) International Alliance was created to coordinate the research work and align the expert opinion on the subject worldwide. DAR holds an annual conference for the early presentation of new studies, consensus statements, and clinical practice guidelines. This year’s conference was held virtually to attract a larger audience. The conference was held on the 12th and 13th of January 2024. This article presents the advance abstracts of the conference’s communications. The abstracts are grouped under themes to facilitate reading. In conclusion, diabetes remains the most extensively studied health impact of Ramadan fasting. Continued interest is evolving around the newer therapeutic agents and technologies.
Hassanein et al. (Mon,) studied this question.